NCT06662578

Brief Summary

The goal of this clinical trial is to learn if integrating equine therapy in memory workshops in mild to moderate Dementias can improve cognitive function, quality of life and mood. The main question\[s\] it aims to answer is: Does the mediation of a horse in memory workshops increase its effects ? Researchers will compare traditional memory workshops, memory workshops using equine therapy and a control group to see if the equine therapy mediation will increase cognitive functions, mood and quality of life in individuals with mild to moderate Dementias. Participants will participate in 8 weekly sessions of equine therapy memory workshops / traditional memory workshops / a control group will not have any interventions during that period. All subjects will be evaluated pre and post intervention period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

October 26, 2024

Last Update Submit

March 16, 2026

Conditions

Keywords

DementiaEquine therapyNeurocognitive stimulationMemory workshopQuality of lifeAlzheimer'sDepression

Outcome Measures

Primary Outcomes (1)

  • Change in Cognitive Function as Assessed by the Montreal Cognitive Assessment (MoCA)

    Pre and post-intervention period, the Montreal Cognitive Assessment was used to assess cognitive function. Score range: 0 to 30; higher scores indicate better cognitive function

    Baseline and ten weeks after

Secondary Outcomes (2)

  • Change in Depression Symptoms as Assessed by the Geriatric Depression Scale (GDS-15)

    Baseline and ten weeks after

  • Change in Quality of Life as Assessed by the Quality of Life in Alzheimer's Disease (QoL-AD NH)

    Baseline and ten weeks after

Study Arms (3)

Control group

NO INTERVENTION

Traditional memory workshop

ACTIVE COMPARATOR

Neurocognitive stimulation as usual

Other: Traditional memory workshop

Equine assisted therapy memory workshop

EXPERIMENTAL

Neurocognitive stimulation mediated with a horse based on a defined protocol.

Other: Equine assisted therapy memory workshops

Interventions

The participants received 8 weekly sessions of 60 minutes of neurocognitive stimulation, based on French memory workshops.

Also known as: neurocognitive stimulation, cognitive stimulation, memory workshops
Traditional memory workshop

The participants received 8 weekly sessions of 60 minutes, based on traditional memory workshops (French type of neurocognitive stimulation) with the mediation of a horse (example : working on associative memory by selecting which object is used for the horse between 2 presented objects).

Also known as: Animal assisted therapy, Equine therapy, neurocognitive stimulation, Equine mediation
Equine assisted therapy memory workshop

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Have been medically diagnosed with Major Neurocognitive Disorders
  • Scores between 0.5 and 2 on the Cognitive Dementia Rating scale (CDR) (Berg, 1982)
  • Adults of all genders, aged 65 and over; and
  • Willingness to participate in a memory workshop; e) willingness to interact with a horse.

You may not qualify if:

  • Expressed fear, aversion, or has had a negative experience with horses
  • Allergy or other medical condition which did not allow contact with horses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CAJOU

Le Boulou, 66160, France

Location

MeSH Terms

Conditions

DementiaDepression

Interventions

Animal Assisted TherapyEquine-Assisted Therapy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPsychotherapyBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical neuropsychologist

Study Record Dates

First Submitted

October 26, 2024

First Posted

October 29, 2024

Study Start

June 3, 2024

Primary Completion

August 30, 2024

Study Completion

August 30, 2024

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations